SCHEMBL6989644

SCHEMBL6989644

N#Cc1cccc(NC2(C(=O)O)CCCC2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
KMT2A Q03164 2/20 0.51
MAPT P10636 2/20 0.51
MEN1 O00255 1/20 0.51
HIF1A Q16665 2/20 0.51
HTT P42858 1/20 0.50
LMNA P02545 1/20 0.50
CYP2D6 P10635 3/20 0.49
TSHR P16473 2/20 0.49
HSD17B10 Q99714 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 4/20 0.48
GRIN2B Q13224 1/20 0.47
MAPK1 P28482 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
USP2 O75604 1/20 0.47
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991463 0.99 TSHR (0.51) ALDH1A1KMT2AMAPTMEN1HIF1A
SCHEMBL7081753 0.89 LMNA (0.52) ALDH1A1KMT2AMAPTMEN1HIF1A
SCHEMBL7083930 0.88 ALDH1A1 (0.51) ALDH1A1KMT2AMAPTMEN1HIF1A
SCHEMBL7076644 0.88 HIF1A (0.48) ALDH1A1KMT2AMAPTMEN1HIF1A
SCHEMBL19708081 0.82 CYP1A2 (0.57) ALDH1A1KMT2AMAPTMEN1HTT
SCHEMBL19707310 0.79 CYP1A2 (0.54) ALDH1A1KMT2AMAPTMEN1HTT
SCHEMBL7082012 0.78 CYP2D6 (0.59) ALDH1A1HIF1ACYP2D6TSHRHSD17B10
SCHEMBL30666841 0.77 HTT (0.43) ALDH1A1KMT2AMAPTMEN1HIF1A
SCHEMBL3954627 0.76 CYP1A2 (0.61) ALDH1A1CYP1A2HPGD
Hydrochloric Acid SCHEMBL2991144 0.76 CYP1A2 (0.61) ALDH1A1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1443160-A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives MERCK PATENT GMBH (DE) 2003-09-17 CN disclosed
US-20030162814-A1 N-substituted 1-amino-1,1-dialkylcarboxylic acid derivatives MERCK PATENT GMBH (DE) 2003-08-28 US disclosed
EP-1303482-A2 N-SUBSTITUTED-1-AMINO-1,1-DIALKYLCARBOXYLIC ACID DERIVATIVES MERCK PATENT GmbH (DE) 2003-04-23 EP disclosed
WO-2002008177-A2 N-SUBSTITUTED-1-AMINO-1,1-DIALKYLCARBOXYLIC ACID DERIVATIVES MERCK PATENT GMBH (DE) 2002-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162814-A1 N-substituted 1-amino-1,1-dialkylcarboxylic acid derivatives F5, CCNY, F2 ALDH1A1 1315/4885KMT2A 2153/4885MAPT 4873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.